Target-oriented therapy: Emerging drugs for atopic dermatitis.
about
Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapySystemic Treatment of Adult Atopic Dermatitis: A Review.The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis.The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.Novel Therapeutic Approaches to Atopic Dermatitis.Pediatric Dermatology.
P2860
Target-oriented therapy: Emerging drugs for atopic dermatitis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@ast
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@en
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@nl
type
label
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@ast
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@en
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@nl
prefLabel
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@ast
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@en
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@nl
P2860
P1476
Target-oriented therapy: Emerging drugs for atopic dermatitis.
@en
P2093
Felix Lauffer
Johannes Ring
P2860
P356
10.1517/14728214.2016.1146681
P407
P577
2016-01-25T00:00:00Z